These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32616594)

  • 1. Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus
    Sauerhering L; Kupke A; Meier L; Dietzel E; Hoppe J; Gruber AD; Gattenloehner S; Witte B; Fink L; Hofmann N; Zimmermann T; Goesmann A; Nist A; Stiewe T; Becker S; Herold S; Peteranderl C
    Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32616594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
    Jeon YJ; Gil CH; Jo A; Won J; Kim S; Kim HJ
    Antiviral Res; 2020 Aug; 180():104860. PubMed ID: 32565134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model.
    Li HS; Kuok DIT; Cheung MC; Ng MMT; Ng KC; Hui KPY; Peiris JSM; Chan MCW; Nicholls JM
    Antiviral Res; 2018 Jul; 155():89-96. PubMed ID: 29772254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    Chang CY; Liu HM; Chang MF; Chang SC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are features of alpacas resolving MERS-CoV infection.
    Te N; Rodon J; Ballester M; Pérez M; Pailler-García L; Segalés J; Vergara-Alert J; Bensaid A
    PLoS Pathog; 2021 May; 17(5):e1009229. PubMed ID: 34029358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
    de Wilde AH; Falzarano D; Zevenhoven-Dobbe JC; Beugeling C; Fett C; Martellaro C; Posthuma CC; Feldmann H; Perlman S; Snijder EJ
    Virus Res; 2017 Jan; 228():7-13. PubMed ID: 27840112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice.
    Dijkman R; Verma AK; Selvaraj M; Ghimire R; Gad HH; Hartmann R; More S; Perlman S; Thiel V; Channappanavar R
    J Virol; 2022 Jun; 96(11):e0036422. PubMed ID: 35588276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B
    Wang Y; Sun J; Li X; Zhu A; Guan W; Sun DQ; Gan M; Niu X; Dai J; Zhang L; Zhang Z; Shi Y; Huang S; Mok CKP; Yang Z; Wang Z; Tan W; Li Y; Chen L; Chen R; Peiris M; Zhong N; Zhao J; Huang J; Zhao J
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study.
    Chan RW; Hemida MG; Kayali G; Chu DK; Poon LL; Alnaeem A; Ali MA; Tao KP; Ng HY; Chan MC; Guan Y; Nicholls JM; Peiris JS
    Lancet Respir Med; 2014 Oct; 2(10):813-22. PubMed ID: 25174549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication.
    Nakagawa K; Narayanan K; Wada M; Makino S
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.
    Berthold EJ; Ma-Lauer Y; Chakraborty A; von Brunn B; Hilgendorff A; Hatz R; Behr J; Hausch F; Staab-Weijnitz CA; von Brunn A
    Front Cell Infect Microbiol; 2022; 12():958634. PubMed ID: 36211973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-Terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b Is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus.
    Li Y; Jin Y; Kuang L; Luo Z; Li F; Sun J; Zhu A; Zhuang Z; Wang Y; Wen L; Liu D; Chen C; Gan M; Zhao J; Zhao J
    J Virol; 2022 Feb; 96(3):e0184221. PubMed ID: 34817197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury.
    Sims AC; Mitchell HD; Gralinski LE; Kyle JE; Burnum-Johnson KE; Lam M; Fulcher ML; West A; Smith RD; Randell SH; Metz TO; Sheahan TP; Waters KM; Baric RS
    mBio; 2021 Aug; 12(4):e0157221. PubMed ID: 34372702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment.
    de Wilde AH; Raj VS; Oudshoorn D; Bestebroer TM; van Nieuwkoop S; Limpens RWAL; Posthuma CC; van der Meer Y; Bárcena M; Haagmans BL; Snijder EJ; van den Hoogen BG
    J Gen Virol; 2013 Aug; 94(Pt 8):1749-1760. PubMed ID: 23620378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation.
    Thornbrough JM; Jha BK; Yount B; Goldstein SA; Li Y; Elliott R; Sims AC; Baric RS; Silverman RH; Weiss SR
    mBio; 2016 Mar; 7(2):e00258. PubMed ID: 27025250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.
    Channappanavar R; Lu L; Xia S; Du L; Meyerholz DK; Perlman S; Jiang S
    J Infect Dis; 2015 Dec; 212(12):1894-903. PubMed ID: 26164863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NS7a of SADS-CoV promotes viral infection via inducing apoptosis to suppress type III interferon production.
    Wang X; Qiu W; Hu G; Diao X; Li Y; Li Y; Li P; Liu Y; Feng Y; Xue C; Cao Y; Xu Z
    J Virol; 2024 May; 98(5):e0031724. PubMed ID: 38624231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.